GeneralConnection.com ➔ Dictionary
Dictionary Search

metastatic

Synonyms

Adjective

1. pathologic process

2. pathological process

Usage
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC - Nature
Can We Outrun Cancer's Evolution? Why BrYet Is Targeting Cancer-Specific Phenotypes - Fierce Biotech
Gopa Iyer, MD, highlights data on anti-Nectin-4 ADC for metastatic urothelial carcinoma - Urology Times
Fatty liver disease fuels aggressive metastatic colorectal cancer spread - News-Medical
32 Primary Breast Neuroendocrine Carcinoma With Synchronous Pancreatic and Liver Metastases: Literature Review of Management Considerations for an Exceptionally Rare Presentation - CancerNetwork
Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours - AstraZeneca
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study - Nature
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors - Business Wire
Daraxonrasib Extends Median Survival in Previously Treated Pancreatic Cancer - The ASCO Post
Palbociclib with trastuzumab regimen approved by the US FDA for HR+, HER2+ metastatic breast cancer - Oncology Central
Marshfield Clinic to offer experimental cancer drug to patients - WSAW
When Time Matters Most, Patients Shouldn’t Have to Wait - U.S. Representative Kathy Castor (.gov)
Spotlighting the BRIA-ABC Trial of Bria-IMT in Metastatic Breast Cancer - OncLive
Revolution Medicines Presents Phase 1/2 Clinical Data for - GlobeNewswire
Overview of Late-Stage Metastatic EGFR-Positive Non-Small Cell Lung Cancer - Cure Today
Organoids unveil key role of transcription factor in colon cancer metastasis - BioTechniques
Foundations of Metastatic TNBC: Biology, Prognosis, and the Treatment Paradigm - OncLive
HER2-Positive Metastatic Breast Cancer Patient Selection and Treatment Duration Considerations - CancerNetwork
Biomarker Testing, the Test-Know-Treat Framework, and Treatment Adherence in Late-Stage Metastatic EGFR-Positive NSCLC - Cure Today
BoneCoT: multicentre validation of a whole-body skeleton foundation model for bone metastases guided by clinician-derived chain of thought - Nature
HR-Positive/HER2-Negative Metastatic Breast Cancer: Managing PI3K-Directed Triplet Therapy and Treatment-Related Toxicities - OncLive
SYNC-T SV-102 Employs Novel Mechanism to Target Immunologically ‘Cold’ Tumors in Advanced Metastatic Prostate Cancer - OncLive
Tremelimumab + durvalumab + chemotherapy vs pembrolizumab + chemotherapy in 1L non-squamous metastatic NSCLC with STK11, KEAP1 and/or KRAS mutations: Interim analysis of the phase 2b TRITON study - OncLive
June’s GI Rewind: CRC, Gastric Cancer See Several “Firsts” With FDA Review of Adjuvant IO, Global Approval of BRAF-Targeted and CAR T-Cell Therapies - OncLive
Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals - Medical Xpress
When “Metastatic Disease” Is Not Metastatic: Diffuse Large B-cell Lymphoma Presenting With a Perisplenic Mass, Pulmonary Masses, Pleural Effusion, and Retroperitoneal Lymphadenopathy - Cureus
Oncologists Weigh Tivozanib Data in Pretreated Metastatic RCC - Targeted Oncology
FDA Approves Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer Treatment - Breast Cancer Research Foundation | BCRF
What Would It Take to Change Brain MRI Surveillance in Metastatic Breast Cancer? - MedPage Today
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer - Nature
SERENA-6 Controversies Push the Breast Cancer Field to Consider the Future Role of ctDNA-Guided Treatment Decisions - OncLive
Ultra-High TMB May Identify a Rare Immunotherapy-Responsive Subgroup in Metastatic Breast Cancer - Oncodaily
The Treatment Landscape: What Failed, What Works, and How to Sequence It - OncLive
Beyond the Baseline: Advances in Triple-Negative Breast Cancer - Docwire News
Metastatic male breast cancer: Joe’s story - Roswell Park Comprehensive Cancer Center
METTL3 protein finds new mechanism driving breast cancer metastasis - Drug Target Review
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial - Nature
Recent Developments in Prostate Cancer - MedPage Today
Novel data support the use of liquid biopsy to guide cetuximab rechallenge in metastatic colorectal cancer - ESMO Daily Reporter
CAPRI-2 GOIM at ESMO GI 2026: Cetuximab Continuation in Molecularly Selected Metastatic Colorectal Cancer - Oncodaily
GLP-1 Agonists Associated With Major Reduction in Metastatic Cancer Progression - Targeted Oncology
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer - AJMC
Steatosis Drives Liver Metastasis Diversity in CRC - Bioengineer.org
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics - Nature
Oncology Drugs Fast-Tracked by the FDA in May and June 2026 - Oncology News Central
FDA Approves Metastatic Breast Cancer Drug Enhertu for Early-Stage Disease - Breast Cancer Research Foundation | BCRF
New mechanism behind breast cancer metastasis uncovered - Medical Xpress
Preserving Performance Status and the Impact of NALIRIFOX's NCCN Inclusion on Clinical Practice - OncLive
Oligometastatic prostate cancer — bridging the gap between localized and metastatic disease - Nature
Type I interferons induced upon respiratory viral infection impair lung metastatic initiation - PNAS
A New FDA Approval is Changing Treatment Options for HR+/HER2+ Metastatic Breast Cancer - BCRF - Oncodaily
A glucocorticoid–FAS axis controls immune evasion during metastatic seeding - Nature
A New Clinical Trial for Metastatic Breast Cancer Opens - UNC Health
Advanced age increases cancer-specific mortality in bone-only metastatic prostate cancer: a SEER analysis - Nature
German study identifies therapeutic Achilles' heel for advanced colorectal cancer - News-Medical
The potential directing role of chemokines for specific metastatic sites in breast cancer - Nature
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial - Nature
7 Complementary Therapies for Metastatic Breast Cancer Treatment Side Effects - Everyday Health
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer - Harvard Medical School
A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential - Nature
Prostate cancer cells converge to an inflammatory-like state upon metastatic dissemination - Nature
Your next steps if breast cancer becomes metastatic - Roswell Park Comprehensive Cancer Center
Metastatic Breast Cancer: Current and Emerging Treatments - Medscape
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value - Science | AAAS
Leptomeningeal metastatic cancer cells induce a permissive choroid plexus vasculature through extracellular-vesicle-derived 5-HIAA signaling - Nature
Evolutionary characterization of lung cancer metastasis - Nature
Investigational daily pill doubles survival in metastatic pancreatic cancer, study shows - Newsroom | UCLA
Trial offers hope for metastatic pancreatic cancer - Mayo Clinic
Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer - AstraZeneca
Timothée Olivier: RASolute 302, Daraxonrasib in Metastatic Pancreatic Cancer - Oncodaily
Metastatic Breast Cancer Research: An Area of Focus for BCRF - Breast Cancer Research Foundation | BCRF
Doctors Thought He Had Cancer. Then They Found a Tapeworm in His Brain - People.com
Strategic positioning of EZH2 inhibition with enzalutamide in the treatment landscape - OncLive
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer - Wiley & Sons
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer | PharmExec - Pharmaceutical Executive
5 Takeaways from BCRF’s Webinar on Advancements in Metastatic Breast Cancer Care - Breast Cancer Research Foundation | BCRF
Fatty Liver Accelerates Aggressive Cancer Metastasis - Bioengineer.org
Multi-omics evaluation of cell lines as models for metastatic prostate cancer - Nature
FDA Approves Ibrance Combination as New Maintenance Option for HR+/HER2+ Metastatic Breast Cancer - SurvivorNet
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer - Pharmaceutical Executive
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer - Yale School of Medicine
Metastatic Breast Cancer Retreat - Northside Hospital
A Mechanophenotyping chip for high-throughput detection of metastatic bacteria-infected circulating tumor cells - Nature
Communicating with patients and families about investigational EZH2 inhibition - OncLive
Metastatic melanoma survivor trusts UT MD Anderson’s expertise and research - UT MD Anderson
Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy - AstraZeneca
Evolving Strategies in the Management of HR+, HER2– Metastatic Breast Cancer - OncLive
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma - Nature
Next-generation HIF-2α inhibitor shows promise in kidney cancer translational clinical trial - Medical Xpress
Inferring cancer type-specific patterns of metastatic spread using Metient - Nature
Does DESTINY-Breast09 Change First-Line Care in HER2-Positive Breast Cancer? - MedPage Today
Nutrient requirements of organ-specific metastasis in breast cancer - Nature
New platform aims to better predict metastatic cancer risk - News at IU
Purple Reign Vs Thriller: A Duel of The Top Frontline EGFR+ NSCLC Regimens - CancerNetwork
FDA Grants Breakthrough Designation to Melanoma Risk Assessment Test - Clinical Lab Products
Editorial: Cancer metastases: mechanisms of tumor dissemination, formation of metastatic niche and anti-metastatic therapy - Frontiers
Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer - The ASCO Post
Completing the Molecular Workup: Mutations, PRAME, and the Case for Early HLA Testing - OncLive
Targeting orthotopic and metastatic pancreatic cancer with allogeneic stem cell–engineered mesothelin-redirected CAR-NKT cells - PNAS
Emerging paradigms in the study of brain metastases - Science | AAAS
Foreign Language Equivalents
Foreign Language Equivalents of 'metastatic'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
metastaric,   metastatix,   mteastatic,   metaststic,   mettastatic,   mmetastatic,   metastativ,   metastati,   mrtastatic,   metsstatic,   metasratic,   metasattic,   metastaticc,   metastaic,   metastattic,   metatatic,   emtastatic,   meetastatic,   metatsatic,   mtastatic,   meyastatic,   metastatoc,   metasyatic,   etastatic,   metasttatic,   metasttic,   metastatiic,   mwtastatic,   merastatic,   metstatic,   metastatci,   metasstatic,   meatstatic,   ,etastatic,   metadtatic,   metastatuc,   metastaitc,   meastatic,   metastayic,   metasttaic,   metaatatic,   netastatic,   metsatatic,   metastatc,   metaastatic,   metastaatic,   metasatic
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z